CLL
Clinical trials for CLL explained in plain language.
Never miss a new study
Get alerted when new CLL trials appear
Sign up with your email to follow new studies for CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to wipe out hidden leukemia cells
Disease control Recruiting nowThis study tests whether adding the drug epcoritamab after standard treatment can help people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) achieve a deeper remission. About 22 adults who have already received at least 12 months of a BTK inhibitor (a…
Matched conditions: CLL
Phase: PHASE2 • Sponsor: Zulfa Omer • Aim: Disease control
Last updated May 17, 2026 10:05 UTC
-
New hope for Tough-to-Treat leukemia: phase 3 trial launches
Disease control Recruiting nowThis study tests a new drug, BGB-16673, against standard treatments (like idelalisib plus rituximab or bendamustine plus rituximab) in 250 adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have already been treated with both BTK and BCL2 inhib…
Matched conditions: CLL
Phase: PHASE3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 17, 2026 10:04 UTC
-
New hope for blood cancer patients: drug combo aims to control relapsed CLL
Disease control Recruiting nowThis study tests whether a new drug, nemtabrutinib, combined with venetoclax works better than the standard venetoclax plus rituximab for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to treatment. Abou…
Matched conditions: CLL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 17, 2026 10:03 UTC
-
New hope for Tough-to-Treat leukemia: phase 3 trial pits rocbrutinib against pirtobrutinib
Disease control Recruiting nowThis study tests a new drug, rocbrutinib, against another drug, pirtobrutinib, in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to prior treatments. About 306 adults will take one of the two pills daily to s…
Matched conditions: CLL
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Massive new registry tracks 8,000 blood cancer patients for decades
Knowledge-focused Recruiting nowThis study is a long-term registry that follows up to 8,000 people with chronic lymphocytic leukemia (CLL) and similar blood cancers. It does not test any new treatment but instead collects information on survival and disease course over many years. Participants must be 18 or old…
Matched conditions: CLL
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC